The Intravenous (IV) Fluid Bags Market is being driven by Increasing prevalence of chronic diseases
The Intravenous (IV) Fluid Bags Market is expected to grow at a CAGR of 6.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 940.5 million. In the healthcare industry, intravenous (IV) fluid bags have been a crucial component in patient care since the 1960s and 1970s. Historically, polyvinyl chloride (PVC) was the primary material used due to its flexibility and cost-effectiveness. However, concerns regarding the environmental impact and potential health risks associated with PVC's production and use of plasticizers have led to a shift in material selection. Modern IV fluid bag manufacturers are now turning to alternative materials such as polyolefins, polyethylene, and polypropylene. These materials offer environmental benefits and reduced hazards to health, making them increasingly popular in the industry. As technology advances, healthcare providers and patients demand more sustainable and safer solutions, and IV fluid bag manufacturers are responding accordingly.
Get more information on Intravenous (IV) Fluid Bags Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
212 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.3% |
Market growth 2025-2029 |
USD 940.5 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
5.7 |
Key countries |
US, China, Germany, Japan, France, UK, Canada, Italy, Brazil, and Spain |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Intravenous (IV) Fluid Bags Market encompasses sterilization of medical devices, chronic disease management for conditions like Crohn's Disease and amino acid deficiency, electrolyte imbalance treatment, and blood bank management. Single-use, sterile, non-latex IV bags ensure safety in applications such as home IV therapy, blood transfusions, and emergency medical supplies. Cold and frozen storage, infection control, and biotechnology advancements contribute to the market's growth. Precision medicine, drug delivery systems, and remote patient monitoring also benefit from IV fluid bags, addressing infection risk, nutrient imbalance, and clinical applications. Innovations in sterile packaging and infection control further bolster the market, with potential applications in kidney infections, hospital settings, and wellness.
The global healthcare supplies market encompasses businesses involved in the research and development of medical consumables, including IV fluid bags, used for managing various health conditions. According to Technavio, the market size is determined by the collective revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, and gowns. Key growth drivers for this market include the increasing elderly population and the rise in chronic diseases. By 2050, approximately one-quarter of the US population and Europe's population by 2030 are projected to be over 60 years old. This demographic shift will increase the demand for IV fluid bags to treat age-related cardiovascular diseases, electrolyte imbalances, and fluid replacement therapy. Additionally, the growing need for non-latex components due to blood-borne illnesses and the prevalence of blood transfusions further boost market growth.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted